AMRI News Alert Albany Molecular Research (AMRI) 16.94 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Albany Molecular Research (AMRI) 16.94 $AMRI

Insider Trading Alert - RTEC, PFE And AMRI Traded By Insiders
at The Street - Fri Feb 13, 10:30AM CST
Stocks with insider trader activity include RTEC, PFE and AMRI
PFE: 34.64 (-0.23), RTEC: 12.14 (-0.17), AMRI: 16.94 (-0.28)

AMRI Realigns Global Operations to Enhance Continuous Supply Chain for Customers
PR Newswire Europe - Thu Feb 12, 3:01PM CST
-- Announces Key Leadership Promotions
AMRI: 16.94 (-0.28)

Albany Molecular Research's (AMRI) CEO Bill Marth on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 1:43PM CST

AMRI: 16.94 (-0.28)

Albany Molecular Research (AMRI) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 12, 7:25AM CST

AMRI: 16.94 (-0.28)

Albany Molecular Research posts 4Q loss
Automated Insights - Thu Feb 12, 7:07AM CST
ALBANY, N.Y. (AP) _ Albany Molecular Research Inc. (AMRI) on Thursday reported a fourth-quarter loss of $1.9 million, after reporting a profit in the same period a year earlier.
AMRI: 16.94 (-0.28)

Albany Molecular misses by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:54AM CST

AMRI: 16.94 (-0.28)

AMRI Announces Fourth Quarter and Full Year 2014 Results
PR Newswire Europe - Thu Feb 12, 6:31AM CST
-- Fourth quarter contract revenue of $80.7 million, up 35% from 2013
AMRI: 16.94 (-0.28)

AMRI Announces Proposal to Close UK-Based API Manufacturing Facility
PR Newswire Europe - Thu Feb 12, 6:31AM CST
AMRI announced today its intention, subject to consultation with its UK workforce, to close its UK facility in Holywell, Wales, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API).
AMRI: 16.94 (-0.28)

5 Hated Earnings Stocks That You Should Love: Pinnacle Entertainment and More
at The Street - Tue Feb 10, 8:02AM CST
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
PNK: 25.64 (-0.35), KN: 18.59 (-3.05), CSOD: 35.03 (+2.02), BCOR: 14.20 (-0.45), AMRI: 16.94 (-0.28)

AMRI Hires Chief Information Officer
PR Newswire Europe - Mon Feb 09, 3:00PM CST
AMRI announced today that Jimmy Wang, Ph.D., fills the newly created position of Chief Information Officer, effective immediately. He replaces Carl Neumann, Senior Director, Information Technology, who retires this month.
AMRI: 16.94 (-0.28)

Analysts View on Health Care Sector Equities -- GlaxoSmithKline, Novartis, Illumina, PerkinElmer, and Albany Molecular Research
PR Newswire - Thu Feb 05, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: GlaxoSmithKline PLC (NYSE: GSK), Novartis AG (NYSE: NVS), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), and Albany Molecular Research Inc. (NASDAQ: AMRI). Free research report on GlaxoSmithKline can be accessed at http://get.Investor-Edge.com/pdf/?c=GlaxoSmit...&s=GSK. On Wednesday, February 04, 2015, the NASDAQ Composite ended at 4,716.70, down 0.23%, the Dow Jones Industrial Average advanced 0.04%, to finish the day at 17,673.02, and the S&P 500 closed at 2,041.51, down 0.42%. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 800.54, down 1.35%, while the index has advanced 2.67% in the previous three months. Register for your complimentary reports at the links given below.
ILMN: 198.54 (+1.81), GSK: 47.94 (+1.99), AMRI: 16.94 (-0.28), PKI: 46.30 (-0.10), NVS: 102.20 (-0.17)

Latest Updates in Healthcare: Special Research on Agios, Akebia, Akers, Akorn, and Albany
PR Newswire - Tue Feb 03, 7:40AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Agios (NASDAQ: AGIO), Akebia (NASDAQ: AKBA), Akers (NASDAQ: AKER), Akorn (NASDAQ: AKRX), and Albany (NASDAQ: AMRI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
AKRX: 47.28 (-0.25), AKER: 3.50 (+0.20), AKBA: 9.32 (+0.51), AGIO: 118.55 (+0.11), AMRI: 16.94 (-0.28)

AMRI to Announce Fourth Quarter and Full Year Results
PR Newswire - Thu Jan 29, 7:00AM CST
AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Thursday, February 12, 2015. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET.
AMRI: 16.94 (-0.28)

Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product
PR Newswire Europe - Mon Jan 26, 3:01AM CST
OXFORD, England, January 26, 2015 /PRNewswire/ --
AMRI: 16.94 (-0.28)

AMRI Receives NIH Contract Award for the Formulation Development and Manufacture of Pre-Clinical and Clinical Drug Product
PR Newswire Europe - Mon Jan 19, 7:01AM CST
- 10-year Federal Contract Award Valued at up to $37 Million -
AMRI: 16.94 (-0.28)

New finance chief at AMRI
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 3:53PM CST

AMRI: 16.94 (-0.28)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 20

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 29

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 12

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 19

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 31

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 20

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 14

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 31

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Dr. Anderson’s Journey: Leadership with Faith and Service

Updated Category News Views 8

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 28

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding EREVs: A Pathway to Successful Electrification

Updated Category News Views 195

Understanding EREVs and Their Role in Electrification As the automotive landscape evolves, consumers find themselves at a crossroads, uncertain about the transition to fully battery electric vehicles (BEVs). In this environment, Extended Range Electric Vehicles (EREVs) emerge as a practical alternative, catering to new-car buyers seeking a balance between traditional...

Continue Reading
Dry Chemistry Analyzer Market Expected to Hit USD 33.2 Billion

Updated Category News Views 154

Overview of the Dry Chemistry Analyzer Market The global dry chemistry analyzer market has set a remarkable trajectory, starting with a valuation of USD 15.2 billion, and is projected to reach an impressive USD 33.2 billion in the upcoming years. This growth is fueled by the increasing necessity for effective diagnostic tools that enhance patient outcomes. These analyzers...

Continue Reading
iPower's Strategic Shift Towards Flexible Funding Solutions

Updated Category News Views 159

iPower's Strategic Move for Enhanced Capital Flexibility iPower Inc. (NASDAQ: IPW), a data-driven e-commerce retailer, is making proactive strides to improve its financial flexibility. The company is exploring diverse funding mechanisms to tailor its financial structure to current market dynamics, ultimately boosting liquidity. Transitioning to Non-Bank Financing...

Continue Reading
Netskope Strengthens Leadership with Wes Simons Appointment

Updated Category News Views 121

Netskope Welcomes Wes Simons as Senior Vice President Netskope has officially welcomed Wes Simons to its executive team as the Senior Vice President of North America Sales. This strategic appointment comes as the company seeks to boost its growth in a key market. With more than 25 years of experience in cybersecurity sales, Simons is poised to be a significant asset for...

Continue Reading
Understanding the Recent Rating Change for Nissan Global Reinsurance

Updated Category News Views 188

AM Best Adjusts Nissan Global Reinsurance's Credit Ratings AM Best recently announced a downgrade of the Financial Strength Rating for Nissan Global Reinsurance, Ltd. (NGRe), reducing it to A- (Excellent) from A (Excellent). Alongside this, the Long-Term Issuer Credit Rating has also been adjusted from "a" (Excellent) to "a-" (Excellent). Notably, the outlook for these...

Continue Reading